NovoCure Limited (NVCR) Stock Price

11.49 ▼ -0.23 (-1.96%)
Open: 11.605 Vol: 0 Day's range: 11.44 - 11.71 Nov 13, 11:38 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NVCR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 11.48▼ 11.53▼ 11.59▼ 11.90▼ 13.33▼
MA10 11.48▼ 11.67▼ 11.77▼ 12.76▼ 14.42▼
MA20 11.51▼ 11.83▼ 11.88▼ 13.65▼ 15.62▼
MA50 11.65▼ 12.03▼ 12.77▼ 14.83▼ 14.46▼
MA100 11.82▼ 12.88▼ 13.26▼ 15.78▼ 15.98▼
MA200 11.91▼ 13.39▼ 13.99▼ 14.79▼ 23.25▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.007▲ -0.034▼ -0.001▼ -0.191▼ -0.587▼
RSI 38.104▼ 28.059▼ 30.484▼ 31.073▼ 36.966▼
STOCH 39.722     5.020▼ 7.803▼ 15.666▼ 14.225▼
WILL %R -70.000     -95.489▼ -95.489▼ -99.143▼ -99.580▼
CCI -76.661     -108.595▼ -151.776▼ -130.926▼ -160.788▼
Latest Filters Detected On NVCR
▼ BREAK $NVCR Price Breaks 60 Days Low Set Alert
▼ BREAK $NVCR Price Breaks 30 Days Low Set Alert
▼ BREAK $NVCR Price Breaks 20 Days Low Set Alert
▼ BREAK $NVCR Price Breaks 10 Days Low Set Alert
NovoCure Limited News
JAMA Network Open Publishes Quality of Life and Pain Outcomes Data from Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields for Pancreatic Cancer
Friday, November 13, 2026 03:30 AM
Novocure (Nasdaq: NVCR) announced today that JAMA Network Open published the results of the prespecified secondary analysis of data from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) ...
FDA rejects NovoCure’s Optune Mya for lung cancer brain metastases. Here's what it means for investors.
Tuesday, November 10, 2026 11:50 AM
The news came shortly after the company reported quarterly earnings that investors found lackluster.
FDA rejects Novocure’s TTFields for brain metastases from lung cancer
Monday, November 09, 2026 07:26 AM
The Swiss developer disclosed that the agency deemed its premarket application for the Optune Mya system as not approvable.
NVCR historical stock data
date open high low close volume
13/11/26 11.605 11.71 11.44 11.47 197,968
12/11/26 11.84 12.11 11.63 11.72 1,246,155
11/11/26 12.01 12.41 11.75 11.99 1,532,911
10/11/26 12.68 12.95 11.56 11.81 1,927,272
09/11/26 12.99 13.225 12.25 12.53 2,373,637
06/11/26 13.52 13.59 13.055 13.28 1,142,574
05/11/26 14.61 14.675 13.49 13.55 1,994,307
04/11/26 14.00 14.94 13.915 14.61 1,645,780
03/11/26 13.30 13.555 13.21 13.43 1,652,338
02/11/26 13.33 13.67 13.08 13.21 1,646,764
Quote Details
52wk Low:9.82
52wk High:21.355
Vol:0
Avg Vol(3m):25.7M
1Y Chng:+5.04%
1M Chng:-24.54%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.40B